See also this year's filing and all EDGAR filings for this company.
PDF Report 0001800373_2024_Goldenwell_Biotech_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.24823379470584225, 'aggregate_val': 143334, 'exp_sum': 190663, 'exp_to_value': {'LiabilitiesLongTerm': 0, 'LiabilitiesCurrent': 0, 'remainder_Liabilities': 190663}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 4.384887922264707e-06, 'aggregate_val': 228057, 'exp_sum': 228056, 'exp_to_value': {'IntangibleAssets': 0, 'AssetsCurrent': 0, 'PropertyPlantAndEquipment': 0, 'remainder_Assets': 228056}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001800373, Goldenwell Biotech INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsCurrent | 0 |
| 2 | PropertyPlantAndEquipment | 0 |
| 3 | remainder_Assets | 228,057 |
| 4 | LiabilitiesLongTerm | 0 |
| 5 | LiabilitiesCurrent | 0 |
| 6 | remainder_Liabilities | 143,334 |
| 7 | GeneralAndAdministrativeExpense | 118,003 |
| 8 | SellingAndMarketingExpense | 0 |
| 9 | remainder_Expenses | 1,232 |
| 10 | remainder_Revenues | 2,340 |
| 11 | remainder_NetIncome | 0 |
| 12 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 228,057 |
| 1 | Liabilities | 143,334 |
| 2 | Expenses | 119,235 |
| 3 | Revenues | 2,340 |
| 4 | StockholdersEquity | 84,723 |
| 5 | NetIncome | -116,895 |
| 6 | ComprehensiveNetIncome | -116,895 |
| 7 | BaseVar | 308,486 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.793 |
| 9 | EconomicCapitalRatio | 0.679 |
Edgar->Model Mapping
Feature Distribution
Change over Time
